Beckman Coulter Posts 6-Percent Rise in Q3 Revenue as Profit Soars 31 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — Beckman Coulter today said that third-quarter revenue increased 6.1 percent as profits jumped 31 percent.
Total receipts for the three months ended Sept. 30 increased to $631.2 million from $593.4 million year over year.
Beckman Coulter attributed the good numbers to increased revenues on consumables, particularly in Europe and, to a lesser extent, in the Far East.
R&D costs in the quarter increased 57 percent to $81 million year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.